Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD | 02-14-2024 | 12-31-2023 | 101 | 621,338,814 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| ALPINE IMMUNE SCIENCES INC | COM | 151 | $4,476,069 | 234,841 | 0.00 | 0.00 | 54,841 | 30.47 | 12-31-2023 |
| ARROWHEAD PHARMACEUTICALS IN | COM | 152 | $4,433,909 | 144,899 | 0.00 | 144,899 | +Inf | 12-31-2023 | |
| AMYLYX PHARMACEUTICALS INC | COM | 153 | $4,175,328 | 283,650 | 0.00 | 0.00 | 90,000 | 46.48 | 12-31-2023 |
| VISTAGEN THERAPEUTICS INC | COM | 154 | $4,155,947 | 808,550 | 0.00 | 0.00 | 708,550 | 708.55 | 12-31-2023 |
